New guidelines on prostate cancer urge frank talk

CHICAGO (Reuters) - New guidelines from the American Cancer Society urge doctors to make sure their patients fully understand the risks as well as the benefits of prostate cancer screening before any blood is drawn.
 

Cigarette smoking may raise prostate cancer risk

NEW YORK (Reuters Health) - Cigarette smoking may increase a man's risk for developing and dying from prostate cancer, pooled data from 24 studies involving 21,600 men with the disease indicates.
 

Movers roundup: Qualcomm, KKR Financial

Movers roundup: Qualcomm shares jump, KKR Financial stock climbs on strong 4Q earnings. Among the stock activity stories for Tuesday, March 2, from AP Financial News:
 

FDA grants final approval for generic Flomax

FDA grants final approval for Impax generic version of Flomax. Drugmaker Impax Laboratories Inc. said Tuesday the Food and Drug Administration gave final approval to its generic version of the enlarged prostate treatment Flomax.
 

Ex-Israel PM Olmert undergoes hernia operation: reports

Former Israeli prime minister Ehud Olmert underwent a hernia operation under full anaesthesia but left hospital hours later, media reports said on Saturday.
 

NY-made robotic surgery simulator rolled out

NY-made robotic surgery simulator going commercial at about $100K per machine. One of the first things Mike Ameroso asked while contemplating robotic surgery for his prostate cancer was how many surgeries his doctors had done with the robot.
 

Statins Slow Inflammation in Prostate Tumors

Anti-cholesterol meds could slow cancer progression. Prostate cancer patients who take statins to lower their cholesterol may be getting a secondary benefit: The drugs significantly lower the degree of inflammation within prostate tumors.
 

Bob Dole hospitalized, undergoing therapy

Former Senate leader and GOP presidential candidate hospitalized after bout with pneumonia. Former Senate Majority Leader Bob Dole is hospitalized at Walter Reed Army Medical Center, undergoing therapy after recovering from pneumonia, his spokesman says.
 

Is newer prostate surgery really better than the old?

NEW YORK (Reuters Health) - Robot-assisted laparoscopic, or "keyhole," surgery appears to be no better at reducing side effects than traditional "open" surgery to remove a cancerous prostate gland, according to new study from Memorial Sloan-Kettering Cancer Center in New York. Critics, however, claim the study relied on old data that doesn't reflect current practice.
 

Houston, We Have a Problem

Every guy loses an erection sometime. It may be during sex. It may be before. The bottom line is, at some point in your life you're going to want sex and your equipment's not going to cooperate. But that doesn't mean you (sex) life is over.
 

Karl coaches first game since cancer disclosure

Nuggets' Karl coaches against Cavaliers in 1st game since revealing he has cancer. Nuggets coach George Karl was on the bench against Cleveland on Thursday night for his first game since disclosing he has neck and throat cancer.
 

J&J drug helps in last-ditch prostate cancer fight

LONDON (Reuters) - Johnson & Johnson's experimental drug abiraterone can help men with advanced prostate cancer who have run out of standard treatments options, according to results of a mid-stage clinical trial.
 

Louis Gossett Jr. fighting prostate cancer

LOS ANGELES (Reuters) - Actor Louis Gossett Jr, best known for his Oscar-winning role as the tough drill instructor in "An Officer and a Gentleman," said on Tuesday he was fighting prostate cancer.
 

Louis Gossett Jr. diagnosed with prostate cancer

Oscar-winning actor Louis Gossett Jr. fighting prostate cancer, expects to make full recovery. Oscar-winning actor Louis Gossett Jr. says he is being treated for prostate cancer.
 

Louis Gossett Jr. fighting prostate cancer

LOS ANGELES (Reuters) - Actor Louis Gossett Jr, best known for his Oscar-winning role as the tough drill instructor in "An Officer and a Gentleman", said on Tuesday he was fighting prostate cancer.
 

Amgen sees positive data in bone drug study

Amgen says potential bone drug tops rival in late-stage study on prostate cancer patients. Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.
 

Prostate cancer diagnosis raises risk of suicide

CHICAGO (Reuters) - Being diagnosed with prostate cancer roughly doubles the risk of suicide or death from a heart attack, U.S. researchers said on Tuesday, adding to the harm linked with diagnosis of this often slow-growing cancer.
 

Hormone drugs for prostate cancer may hurt heart

WASHINGTON (Reuters) - Prostate cancer treatments that cut off the supply of male hormone raise cholesterol, worsen blood sugar and make men fatter and thus likely raise the risk of heart attack, too, doctors said on Monday.
 

Scanner helps doctors pinpoint prostate cancer

CHICAGO (Reuters) - U.S. researchers have found a way to pinpoint where in the prostate a tumor may be hiding by using a imaging technique that measures the chemical composition of tissues.
 

Genetic factors key to prostate cancer death risk

LONDON (Reuters) - A combination of three genetic abnormalities has a dramatic impact on how long prostate cancer patients are likely to live, researchers said on Wednesday, and gene tests could help doctors decide on the best treatments.